Arxis, Inc. · NASDAQ:ARXS
Oetgen Stephen Duane bought 25,000 Arxis, Inc. shares (Form 4)
Traded Apr 17, 2026 · Filed Apr 20, 2026
On Apr 17, 2026, Oetgen Stephen Duane (Director) bought 25,000 Arxis, Inc. shares at US$28.00 for US$700K, leaving 30,357 shares. Filed Apr 20, 2026 (Form 4).
- Bought
- 25,000 shares
- Price
- US$28.00
- Value
- US$700K
- Holding after
- 30,357 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 17, 2026 | Class A Common Stock | Award | 5,357 | 5,357 | Direct | |
| Apr 17, 2026 | Class A Common Stock | Buy | 25,000 | US$28.00 | 30,357 | Direct |
Source
Related
- Arxis, Inc.
- Oetgen Stephen Duane
- Arxis, Inc. shareholders
- Schedule 13G · Gerald W. Simonson Revocable Trust Agreement Dated May 12, 2016 as amended · Sep 21, 2026
- Form 4 · Roth Jason Aaron · Aug 21, 2026
- Schedule 13G · Arcline Investment Management, L.P. · Aug 14, 2026
- Schedule 13G · Capital Research Global Investors · Aug 12, 2026
- Schedule 13G · Capital International Investors · Aug 12, 2026